메뉴 건너뛰기




Volumn 103, Issue 4, 2014, Pages 308-314

Ivabradine improves heart rate variability in patients with nonischemic dilated cardiomyopathy

Author keywords

Anti arrhythmia agents therapeutic use; Cardiomyopathy; Dilated; Heart rate

Indexed keywords

ALDOSTERONE ANTAGONIST; AMIODARONE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARDIAC GLYCOSIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IVABRADINE; BENZAZEPINE DERIVATIVE; CARDIOTONIC AGENT;

EID: 84907463060     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20140109     Document Type: Article
Times cited : (20)

References (40)
  • 1
    • 84864493727 scopus 로고    scopus 로고
    • ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC
    • McMurray JJ, Adamopoulos S, Anker SD, Auricchio A, Böhm M, Dickstein K, et al; ESC Committee for Practice Guidelines. ESC guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association (HFA) of the ESC. Eur Heart J. 2012;33(14):1787-847.
    • (2012) Eur Heart J , vol.33 , Issue.14 , pp. 1787-1847
    • McMurray, J.J.1    Adamopoulos, S.2    Anker, S.D.3    Auricchio, A.4    Böhm, M.5    Dickstein, K.6
  • 2
    • 60449094498 scopus 로고    scopus 로고
    • Heart disease and stroke statistics-2009 update: A report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee
    • Lloyd-Jones D, Adams R, Carnethon M, De Simone G, Ferguson TB, Flegal K, et al. Heart disease and stroke statistics-2009 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation. 2009;119(3):480-6.
    • (2009) Circulation , vol.119 , Issue.3 , pp. 480-486
    • Lloyd-Jones, D.1    Adams, R.2    Carnethon, M.3    De Simone, G.4    Ferguson, T.B.5    Flegal, K.6
  • 3
    • 0042357093 scopus 로고    scopus 로고
    • Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology
    • Camm AJ, Lau CP. Electrophysiological effects of a single intravenous administration of ivabradine (S 16257) in adult patients with normal baseline electrophysiology. Drugs. 2003;4(2):83-9.
    • (2003) Drugs , vol.4 , Issue.2 , pp. 83-89
    • Camm, A.J.1    Lau, C.P.2
  • 4
    • 0344394916 scopus 로고    scopus 로고
    • A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction
    • Manz M, Reuter M, Lauck G, Omran H, Jung W. A single intravenous dose of ivabradine, a novel I(f) inhibitor, lowers heart rate but does not depress left ventricular function in patients with left ventricular dysfunction. Cardiology. 2003;100(3):149-55.
    • (2003) Cardiology , vol.100 , Issue.3 , pp. 149-155
    • Manz, M.1    Reuter, M.2    Lauck, G.3    Omran, H.4    Jung, W.5
  • 5
    • 84859210318 scopus 로고    scopus 로고
    • Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm
    • Parakh N, Chaturvedi V, Kurian S, Tyagi S. Effect of ivabradine vs atenolol on heart rate and effort tolerance in patients with mild to moderate mitral stenosis and normal sinus rhythm. J Card Fail. 2012;18(4):282-8.
    • (2012) J Card Fail , vol.18 , Issue.4 , pp. 282-288
    • Parakh, N.1    Chaturvedi, V.2    Kurian, S.3    Tyagi, S.4
  • 6
    • 77956612624 scopus 로고    scopus 로고
    • Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study
    • Swedberg K, Komajda M, Böhm M, Borer JS, Ford I, Dubost-Brama A, et al. Ivabradine and outcomes in chronic heart failure (SHIFT): A randomised placebo-controlled study. Lancet. 2010;376(9744):875-85.
    • (2010) Lancet , vol.376 , Issue.9744 , pp. 875-885
    • Swedberg, K.1    Komajda, M.2    Böhm, M.3    Borer, J.S.4    Ford, I.5    Dubost-Brama, A.6
  • 7
    • 0029928495 scopus 로고    scopus 로고
    • Heart rate variability: Standards of measurement, physiological interpretation and clinical use
    • Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology
    • Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. Heart rate variability: standards of measurement, physiological interpretation and clinical use. Circulation. 1996;93(5):1043-65.
    • (1996) Circulation , vol.93 , Issue.5 , pp. 1043-1065
  • 8
    • 0030222178 scopus 로고    scopus 로고
    • Short and long-term reproducibility of time and frequency domain heart rate variability measurements in normal subjects
    • Pitzalis MV, Mastropasqua F, Massari F, Forleo C, Di Maggio M, Passantino A, et al. Short and long-term reproducibility of time and frequency domain heart rate variability measurements in normal subjects. Cardiovasc Res. 1996;32(2):226-33.
    • (1996) Cardiovasc Res , vol.32 , Issue.2 , pp. 226-233
    • Pitzalis, M.V.1    Mastropasqua, F.2    Massari, F.3    Forleo, C.4    Di Maggio, M.5    Passantino, A.6
  • 9
    • 0037211978 scopus 로고    scopus 로고
    • Prognostic significance of heart rate variability in dilated cardiomyopathy
    • Karcz M, Chojnowska L, Zareba W, Ruzyllo W. Prognostic significance of heart rate variability in dilated cardiomyopathy. Int J Cardiol. 2003;87(1):75-81.
    • (2003) Int J Cardiol , vol.87 , Issue.1 , pp. 75-81
    • Karcz, M.1    Chojnowska, L.2    Zareba, W.3    Ruzyllo, W.4
  • 10
    • 0030865310 scopus 로고    scopus 로고
    • Heart rate variability in idiopathic dilated cardiomyopathy: Characteristics and prognostic value
    • Fauchier L, Babuty D, Cosnay P, Autret ML, Fauchier JP. Heart rate variability in idiopathic dilated cardiomyopathy: characteristics and prognostic value. J Am Coll Cardiol. 1997;30(4):1009-14.
    • (1997) J Am Coll Cardiol , vol.30 , Issue.4 , pp. 1009-1014
    • Fauchier, L.1    Babuty, D.2    Cosnay, P.3    Autret, M.L.4    Fauchier, J.P.5
  • 11
    • 0030229169 scopus 로고    scopus 로고
    • Heart rate variability: Two eras of investigation
    • Binkley PF. Heart rate variability: two eras of investigation. J Card Fail. 1996;2(3):193-6.
    • (1996) J Card Fail , vol.2 , Issue.3 , pp. 193-196
    • Binkley, P.F.1
  • 12
    • 0036642639 scopus 로고    scopus 로고
    • Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure)
    • Bilchick KC, Fetics B, Djoukeng R, Fisher SG, Fletcher RD, Singh SN, et al. Prognostic value of heart rate variability in chronic congestive heart failure (Veterans Affairs’ Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure). Am J Cardiol. 2002;90(1):24-8.
    • (2002) Am J Cardiol , vol.90 , Issue.1 , pp. 24-28
    • Bilchick, K.C.1    Fetics, B.2    Djoukeng, R.3    Fisher, S.G.4    Fletcher, R.D.5    Singh, S.N.6
  • 14
    • 84885304142 scopus 로고    scopus 로고
    • ASSOCIATE investigators. Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: An analysis of the ASSOCIATE study
    • Tardif JC, Ponikowski P, Kahan T; ASSOCIATE investigators. Effects of ivabradine in patients with stable angina receiving beta-blockers according to baseline heart rate: an analysis of the ASSOCIATE study. Int J Cardiol. 2013;168(2):789-94.
    • (2013) Int J Cardiol , vol.168 , Issue.2 , pp. 789-794
    • Tardif, J.C.1    Ponikowski, P.2    Kahan, T.3
  • 15
    • 78650451971 scopus 로고    scopus 로고
    • American Society of Echocardiography recommendations for quality echocardiography laboratory operations
    • Picard MH, Adams D, Bierig SM, Dent JM, Douglas PS, Gillam LD, et al. American Society of Echocardiography recommendations for quality echocardiography laboratory operations. J Am Soc Echocardiogr. 2011;24(1):1-10.
    • (2011) J Am Soc Echocardiogr , vol.24 , Issue.1 , pp. 1-10
    • Picard, M.H.1    Adams, D.2    Bierig, S.M.3    Dent, J.M.4    Douglas, P.S.5    Gillam, L.D.6
  • 16
    • 4544344025 scopus 로고    scopus 로고
    • Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: A new therapeutic perspective in cardiovascular disease
    • Di Francesco D, Camm AJ. Heart rate lowering by specific and selective I(f) current inhibition with ivabradine: a new therapeutic perspective in cardiovascular disease. Drugs. 2004;64(16):1757-65.
    • (2004) Drugs , vol.64 , Issue.16 , pp. 1757-1765
    • Di Francesco, D.1    Camm, A.J.2
  • 17
    • 33645513944 scopus 로고    scopus 로고
    • Properties of ivabradine induced block of HCN1 and HCN4 pacemaker channels
    • Bucchi A, Tognati A, Milanesi R, Baruscotti M, DiFrancesco D. Properties of ivabradine induced block of HCN1 and HCN4 pacemaker channels. J Physiol. 2006;572(Pt 2):335-46.
    • (2006) J Physiol , vol.572 , pp. 335-346
    • Bucchi, A.1    Tognati, A.2    Milanesi, R.3    Baruscotti, M.4    Difrancesco, D.5
  • 18
    • 70349669250 scopus 로고    scopus 로고
    • BEAUTIFUL Investigators. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: A subgroup analysis of the randomized, controlled BEAUTIFUL trial
    • Fox K, Ford I, Steg PG, Tendera M, Robertson M, Ferrari R; BEAUTIFUL Investigators. Relationship between ivabradine treatment and cardiovascular outcomes in patients with stable coronary artery disease and left ventricular systolic dysfunction with limiting angina: a subgroup analysis of the randomized, controlled BEAUTIFUL trial. Eur Heart J. 2009;30(19):2337-45.
    • (2009) Eur Heart J , vol.30 , Issue.19 , pp. 2337-2345
    • Fox, K.1    Ford, I.2    Steg, P.G.3    Tendera, M.4    Robertson, M.5    Ferrari, R.6
  • 19
    • 78651275247 scopus 로고    scopus 로고
    • Impact of ‘’off-label’’ use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure
    • Sarullo FM, Fazio G, Puccio D, Fasullo S, Paterna S, Novo S, et al. Impact of ‘’off-label’’ use of ivabradine on exercise capacity, gas exchange, functional class, quality of life, and neurohormonal modulation in patients with ischemic chronic heart failure. J Cardiovasc Pharmacol Ther. 2010;15(4):349-55.
    • (2010) J Cardiovasc Pharmacol Ther , vol.15 , Issue.4 , pp. 349-355
    • Sarullo, F.M.1    Fazio, G.2    Puccio, D.3    Fasullo, S.4    Paterna, S.5    Novo, S.6
  • 20
    • 80052322413 scopus 로고    scopus 로고
    • Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial)
    • Volterrani M, Cice G, Caminiti G, Vitale C, D’Isa S, Perrone Filardi P, et al. Effect of Carvedilol, Ivabradine or their combination on exercise capacity in patients with Heart Failure (the CARVIVA HF trial). Int J Cardiol. 2011;151(2):218-24.
    • (2011) Int J Cardiol , vol.151 , Issue.2 , pp. 218-224
    • Volterrani, M.1    Cice, G.2    Caminiti, G.3    Vitale, C.4    D’isa, S.5    Perrone Filardi, P.6
  • 21
    • 70450224100 scopus 로고    scopus 로고
    • Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: Preliminary findings
    • Fasullo S, Cannizzaro S, Maringhini G, Ganci F, Giambanco F, Vitale G, et al. Comparison of ivabradine versus metoprolol in early phases of reperfused anterior myocardial infarction with impaired left ventricular function: preliminary findings. J Card Fail. 2009;15(10):856-63.
    • (2009) J Card Fail , vol.15 , Issue.10 , pp. 856-863
    • Fasullo, S.1    Cannizzaro, S.2    Maringhini, G.3    Ganci, F.4    Giambanco, F.5    Vitale, G.6
  • 22
    • 0027955938 scopus 로고
    • Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study
    • Tsuji H, Venditti FJ Jr, Manders ES, Evans JC, Larson MG, Feldman CL, et al. Reduced heart rate variability and mortality risk in an elderly cohort. The Framingham Heart Study. Circulation. 1994;90(2):878-83.
    • (1994) Circulation , vol.90 , Issue.2 , pp. 878-883
    • Tsuji, H.1    Venditti, F.J.2    Manders, E.S.3    Evans, J.C.4    Larson, M.G.5    Feldman, C.L.6
  • 23
    • 77955444570 scopus 로고    scopus 로고
    • Differences in autonomic activity in individuals with optimal, normal, and high-normal blood pressure levels
    • Doğru MT, Simşek V, Sahin O, Ozer N. Differences in autonomic activity in individuals with optimal, normal, and high-normal blood pressure levels. Turk Kardiyol Dern Ars. 2010;38(3):182-8.
    • (2010) Turk Kardiyol Dern Ars , vol.38 , Issue.3 , pp. 182-188
    • Doğru, M.T.1    Simşek, V.2    Sahin, O.3    Ozer, N.4
  • 24
    • 84877108264 scopus 로고    scopus 로고
    • Heart rate variability and heart rate recovery in patients with type 1 diabetes mellitus
    • Turker Y, Aslantas Y, Aydin Y, Demirin H, Kutlucan A, Tibilli H, et al. Heart rate variability and heart rate recovery in patients with type 1 diabetes mellitus. Acta Cardiol. 2013;68(2):145-50.
    • (2013) Acta Cardiol , vol.68 , Issue.2 , pp. 145-150
    • Turker, Y.1    Aslantas, Y.2    Aydin, Y.3    Demirin, H.4    Kutlucan, A.5    Tibilli, H.6
  • 25
    • 84881141413 scopus 로고    scopus 로고
    • Relation of short term heart rate variability to incident heart failure (from the Multi Ethnic Study of Atherosclerosis)
    • Shah SA, Kambur T, Chan C, Herrington DM, Liu K, Shah SJ. Relation of short‑term heart rate variability to incident heart failure (from the Multi‑Ethnic Study of Atherosclerosis). Am J Cardiol. 2013;112(4):533-40.
    • (2013) Am J Cardiol , vol.112 , Issue.4 , pp. 533-540
    • Shah, S.A.1    Kambur, T.2    Chan, C.3    Herrington, D.M.4    Liu, K.5    Shah, S.J.6
  • 26
    • 84872264274 scopus 로고    scopus 로고
    • Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty
    • Coviello I, Pinnacchio G, Laurito M, Stazi A, Battipaglia I, Barone L, et al. Prognostic role of heart rate variability in patients with ST-segment elevation acute myocardial infarction treated by primary angioplasty. Cardiology. 2013;124(1):63-70.
    • (2013) Cardiology , vol.124 , Issue.1 , pp. 63-70
    • Coviello, I.1    Pinnacchio, G.2    Laurito, M.3    Stazi, A.4    Battipaglia, I.5    Barone, L.6
  • 27
    • 69949088284 scopus 로고    scopus 로고
    • Heart rate variability increases with reductions in cigarette smoke exposure after 3 days
    • Munjal S, Koval T, Muhammad R, Jin Y, Demmel V, Roethig HJ, et al. Heart rate variability increases with reductions in cigarette smoke exposure after 3 days. J Cardiovasc Pharmacol Ther. 2009;14(3):192-8.
    • (2009) J Cardiovasc Pharmacol Ther , vol.14 , Issue.3 , pp. 192-198
    • Munjal, S.1    Koval, T.2    Muhammad, R.3    Jin, Y.4    Demmel, V.5    Roethig, H.J.6
  • 28
    • 0842281506 scopus 로고    scopus 로고
    • Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease
    • Antelmi I, de Paula RS, Shinzato AR, Peres CA, Mansur AJ, Grupi CJ. Influence of age, gender, body mass index, and functional capacity on heart rate variability in a cohort of subjects without heart disease. Am J Cardiol. 2004;93(3):381-5.
    • (2004) Am J Cardiol , vol.93 , Issue.3 , pp. 381-385
    • Antelmi, I.1    De Paula, R.S.2    Shinzato, A.R.3    Peres, C.A.4    Mansur, A.J.5    Grupi, C.J.6
  • 29
    • 84887767930 scopus 로고    scopus 로고
    • Impaired heart rate variability in patients with mitral annular calcification: An observational study
    • Kurtoglu E, Akturk E, Korkmaz H, Atas H, Cuglan B, Pekdemir H. Impaired heart rate variability in patients with mitral annular calcification: an observational study. Anadolu Kardiyol Derg. 2013;13(7):668-74.
    • (2013) Anadolu Kardiyol Derg , vol.13 , Issue.7 , pp. 668-674
    • Kurtoglu, E.1    Akturk, E.2    Korkmaz, H.3    Atas, H.4    Cuglan, B.5    Pekdemir, H.6
  • 30
    • 0034991027 scopus 로고    scopus 로고
    • Effect of beta-blockade on heart rate variability in decompensated heart failure
    • Aronson D, Burger AJ. Effect of beta-blockade on heart rate variability in decompensated heart failure. Int J Cardiol. 2001;79(1):31-9.
    • (2001) Int J Cardiol , vol.79 , Issue.1 , pp. 31-39
    • Aronson, D.1    Burger, A.J.2
  • 31
    • 29144455179 scopus 로고    scopus 로고
    • Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure
    • Bullinga JR, Alharethi R, Schram MS, Bristow MR, Gilbert EM. Changes in heart rate variability are correlated to hemodynamic improvement with chronic CARVEDILOL therapy in heart failure. J Card Fail. 2005;11(9):693-9.
    • (2005) J Card Fail , vol.11 , Issue.9 , pp. 693-699
    • Bullinga, J.R.1    Alharethi, R.2    Schram, M.S.3    Bristow, M.R.4    Gilbert, E.M.5
  • 32
    • 0033059974 scopus 로고    scopus 로고
    • The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy
    • Jansson K, Hagerman I, Ostlund R, Karlberg KE, Nylander E, Nyquist O, et al. The effects of metoprolol and captopril on heart rate variability in patients with idiopathic dilated cardiomyopathy. Clin Cardiol. 1999;22(6):397-402.
    • (1999) Clin Cardiol , vol.22 , Issue.6 , pp. 397-402
    • Jansson, K.1    Hagerman, I.2    Ostlund, R.3    Karlberg, K.E.4    Nylander, E.5    Nyquist, O.6
  • 33
    • 2542523785 scopus 로고    scopus 로고
    • Beneficial effect of candesartan treatment on cardiac autonomic nervous activity in patients with chronic heart failure: Simultaneous recording of ambulatory electrocardiogram and posture
    • Tambara K, Fujita M, Sumita Y, Miyamoto S, Sekiguchi H, Eiho S, et al. Beneficial effect of candesartan treatment on cardiac autonomic nervous activity in patients with chronic heart failure: simultaneous recording of ambulatory electrocardiogram and posture. Clin Cardiol. 2004;27(5):300-3.
    • (2004) Clin Cardiol , vol.27 , Issue.5 , pp. 300-303
    • Tambara, K.1    Fujita, M.2    Sumita, Y.3    Miyamoto, S.4    Sekiguchi, H.5    Eiho, S.6
  • 34
    • 1542496392 scopus 로고    scopus 로고
    • Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure
    • De Tommasi E, Iacoviello M, Romito R, Ceconi C, Guida P, Massari F, et al. Comparison of the effect of valsartan and lisinopril on autonomic nervous system activity in chronic heart failure. Am Heart J. 2003;146(5):E17.
    • (2003) Am Heart J , vol.146 , Issue.5 , pp. E17
    • De Tommasi, E.1    Iacoviello, M.2    Romito, R.3    Ceconi, C.4    Guida, P.5    Massari, F.6
  • 35
    • 0035370038 scopus 로고    scopus 로고
    • Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure
    • Yee KM, Pringle SD, Struthers AD. Circadian variation in the effects of aldosterone blockade on heart rate variability and QT dispersion in congestive heart failure. J Am Coll Cardiol. 2001;37(7):1800-7.
    • (2001) J Am Coll Cardiol , vol.37 , Issue.7 , pp. 1800-1807
    • Yee, K.M.1    Pringle, S.D.2    Struthers, A.D.3
  • 36
    • 33646750506 scopus 로고    scopus 로고
    • Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction
    • Gislason GH, Rasmussen V, Abildstrom SZ, Gadsboll N, Buch P, Friberg J, et al. Long-term compliance with beta-blockers, angiotensin-converting enzyme inhibitors, and statins after acute myocardial infarction. Eur Heart J. 2006;27(10):1153-8.
    • (2006) Eur Heart J , vol.27 , Issue.10 , pp. 1153-1158
    • Gislason, G.H.1    Rasmussen, V.2    Abildstrom, S.Z.3    Gadsboll, N.4    Buch, P.5    Friberg, J.6
  • 37
    • 72449138051 scopus 로고    scopus 로고
    • Challenging the dogma of high target doses in the treatment of heart failure: Is more always better?
    • Follath F. Challenging the dogma of high target doses in the treatment of heart failure: is more always better? Arch Cardiovasc Dis. 2009;102(11):785-9.
    • (2009) Arch Cardiovasc Dis , vol.102 , Issue.11 , pp. 785-789
    • Follath, F.1
  • 38
    • 78650921528 scopus 로고    scopus 로고
    • Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis
    • Busseuil D, Shi Y, Mecteau M, Brand G, Gillis MA, Thorin E, et al. Heart rate reduction by ivabradine reduces diastolic dysfunction and cardiac fibrosis. Cardiology. 2010;117(3):234-42.
    • (2010) Cardiology , vol.117 , Issue.3 , pp. 234-242
    • Busseuil, D.1    Shi, Y.2    Mecteau, M.3    Brand, G.4    Gillis, M.A.5    Thorin, E.6
  • 39
    • 80054742115 scopus 로고    scopus 로고
    • SHIFT Investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: Results from the SHIFT echocardiography substudy
    • Tardif JC, O’Meara E, Komajda M, Böhm M, Borer JS, Ford I, et al; SHIFT Investigators. Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy. Eur Heart J. 2011;32(20):2507-15.
    • (2011) Eur Heart J , vol.32 , Issue.20 , pp. 2507-2515
    • Tardif, J.C.1    O’meara, E.2    Komajda, M.3    Böhm, M.4    Borer, J.S.5    Ford, I.6
  • 40
    • 44949127974 scopus 로고    scopus 로고
    • Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice
    • Drouin A, Gendron ME, Thorin E, Gillis MA, Mahlberg-Gaudin F, Tardif JC. Chronic heart rate reduction by ivabradine prevents endothelial dysfunction in dyslipidaemic mice. Br J Pharmacol. 2008;154(4):749-57.
    • (2008) Br J Pharmacol , vol.154 , Issue.4 , pp. 749-757
    • Drouin, A.1    Gendron, M.E.2    Thorin, E.3    Gillis, M.A.4    Mahlberg-Gaudin, F.5    Tardif, J.C.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.